Acquired by DNA Capital
June, 2021
monashees participated in the early-stage and series A rounds, sat on the Board of Directors and worked alongside founders and leadership team for more than 4 years.
Memed offers an electronic prescription solution that directly benefits three players in the healthcare value chain: doctors, patients and pharmacists. Doctors can prescribe medication more safely and with more information, patients receive their prescriptions in a digital, legible form with more information, and pharmacies can make sales with bigger discounts and less bureaucracy.
Co-investors include
DNA Capital, Redpoint e.Ventures, Qualcomm Ventures
- Founded in2012
- StatusPast
- HeadquartersSão Paulo